400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / Laninamivir octanoate
CAS No.: 203120-46-1
Synonyms: CS-8958;Laninamivir Octanoate;R-125489
Laninamivir octanoate is a neuraminidase inhibitor that exhibits clinical efficacy for both treatment and prophylaxis of influenza virus infection, resulting from hydrolytic bioactivation into its pharmacologically active metabolite laninamivir in the pulmonary tissue.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00657111 | Influenza | Phase 1 | Completed | - | United Kingdom ... more >> Covance Clinical Research Unit Ltd (Covance CRU) Leeds, United Kingdom, LS2 9LH Collapse << |
NCT00995826 | Influenza | Phase 1 | Completed | - | United Kingdom ... more >> Covance Clinical Research Unit Limited Leeds, United Kingdom Collapse << |
NCT01793883 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 203120-46-1 | 储存条件 |
|
|
分子式 | C21H36N4O8 | 运输 | 蓝冰 | |
分子量 | 472.53 | 别名 | CS-8958;Laninamivir Octanoate;R-125489 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00657111 | Influenza | Phase 1 | Completed | - | United Kingdom ... more >> Covance Clinical Research Unit Ltd (Covance CRU) Leeds, United Kingdom, LS2 9LH Collapse << |
NCT00995826 | Influenza | Phase 1 | Completed | - | United Kingdom ... more >> Covance Clinical Research Unit Limited Leeds, United Kingdom Collapse << |
NCT01793883 | - | - | Completed | - | - |
NCT02014649 | Influenza | Phase 1 Phase 2 | Terminated(Study was terminate... more >>d as per BARDA decision to terminate contract.) Collapse << | - | - |
NCT02022761 | Asthma | Phase 1 | Completed | - | United Kingdom ... more >> Respiratory Clinical Trials London, United Kingdom, W1G 8HU Collapse << |
NCT01793883 | Influenza | Phase 2 | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网